H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 1,603,797. Pennsylvania Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Philadelphia clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Philadelphia storefront.
Sports Injury Biologic Treatments in Philadelphia, PA for clinics & physicians. Biologic treatments for sp… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Philadelphia is JL (Novitas Solutions) and that adult diabetes here is not published at city grain — use national 12%, it is selling units, not a program. That is the sports injury biologics conversation we actually have.
National Sports Injury Biologic Treatments notes (how the product actually works)We do not have a CDC PLACES uninsured rate for Philadelphia. Expect a mix of JL fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. A city of 1M+ with 1,603,797 residents will still mix those payers. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the sports injury biologics account.
CDC PLACES has no incorporated-place row we could match for Philadelphia. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
Regulatory lane, storage, and JL coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Pennsylvania is in CMS MAC JL, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Philadelphia.
Bring specialty, monthly joint / regenerative volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Philadelphia, PA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Philadelphia is JL geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Pennsylvania Part B wound biologics follow this contractor (siblings: DC, DE, MD, NJ). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 1M+, not a count of orthopedic groups.
No Philadelphia storefront. Joe Bradley is an active practice owner. sports injury biologics stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.